195 related articles for article (PubMed ID: 8752296)
1. Virus-like particles as a rotavirus subunit vaccine.
Conner ME; Zarley CD; Hu B; Parsons S; Drabinski D; Greiner S; Smith R; Jiang B; Corsaro B; Barniak V; Madore HP; Crawford S; Estes MK
J Infect Dis; 1996 Sep; 174 Suppl 1():S88-92. PubMed ID: 8752296
[TBL] [Abstract][Full Text] [Related]
2. Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity.
Ciarlet M; Crawford SE; Barone C; Bertolotti-Ciarlet A; Ramig RF; Estes MK; Conner ME
J Virol; 1998 Nov; 72(11):9233-46. PubMed ID: 9765471
[TBL] [Abstract][Full Text] [Related]
3. Rotavirus subunit vaccines.
Conner ME; Crawford SE; Barone C; O'Neal C; Zhou YJ; Fernandez F; Parwani A; Saif LJ; Cohen J; Estes MK
Arch Virol Suppl; 1996; 12():199-206. PubMed ID: 9015116
[TBL] [Abstract][Full Text] [Related]
4. Rotavirus virus-like particles administered mucosally induce protective immunity.
O'Neal CM; Crawford SE; Estes MK; Conner ME
J Virol; 1997 Nov; 71(11):8707-17. PubMed ID: 9343229
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice.
Bertolotti-Ciarlet A; Ciarlet M; Crawford SE; Conner ME; Estes MK
Vaccine; 2003 Sep; 21(25-26):3885-900. PubMed ID: 12922123
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and immunologic comparison of virus-like particles for a rotavirus subunit vaccine.
Madore HP; Estes MK; Zarley CD; Hu B; Parsons S; Digravio D; Greiner S; Smith R; Jiang B; Corsaro B; Barniak V; Crawford S; Conner ME
Vaccine; 1999 May; 17(19):2461-71. PubMed ID: 10392629
[TBL] [Abstract][Full Text] [Related]
7. Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles.
Jiang B; Estes MK; Barone C; Barniak V; O'Neal CM; Ottaiano A; Madore HP; Conner ME
Vaccine; 1999 Feb; 17(7-8):1005-13. PubMed ID: 10067709
[TBL] [Abstract][Full Text] [Related]
8. Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles.
Crawford SE; Estes MK; Ciarlet M; Barone C; O'Neal CM; Cohen J; Conner ME
J Virol; 1999 Jun; 73(6):4813-22. PubMed ID: 10233942
[TBL] [Abstract][Full Text] [Related]
9. Isotype-specific antibody responses to rotavirus and virus proteins in cows inoculated with subunit vaccines composed of recombinant SA11 rotavirus core-like particles (CLP) or virus-like particles (VLP).
Fernandez FM; Conner ME; Parwani AV; Todhunter D; Smith KL; Crawford SE; Estes MK; Saif LJ
Vaccine; 1996 Oct; 14(14):1303-12. PubMed ID: 9004438
[TBL] [Abstract][Full Text] [Related]
10. Lactogenic antibody responses in cows vaccinated with recombinant bovine rotavirus-like particles (VLPs) of two serotypes or inactivated bovine rotavirus vaccines.
Kim Y; Nielsen PR; Hodgins D; Chang KO; Saif LJ
Vaccine; 2002 Jan; 20(7-8):1248-58. PubMed ID: 11803088
[TBL] [Abstract][Full Text] [Related]
11. Magnitude of serum and intestinal antibody responses induced by sequential replicating and nonreplicating rotavirus vaccines in gnotobiotic pigs and correlation with protection.
Azevedo MS; Yuan L; Iosef C; Chang KO; Kim Y; Nguyen TV; Saif LJ
Clin Diagn Lab Immunol; 2004 Jan; 11(1):12-20. PubMed ID: 14715539
[TBL] [Abstract][Full Text] [Related]
12. Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential.
Redmond MJ; Ijaz MK; Parker MD; Sabara MI; Dent D; Gibbons E; Babiuk LA
Vaccine; 1993; 11(2):273-81. PubMed ID: 8382422
[TBL] [Abstract][Full Text] [Related]
13. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
Choi AH; Basu M; Rae MN; McNeal MM; Ward RL
Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437
[TBL] [Abstract][Full Text] [Related]
14. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
Siadat-Pajouh M; Cai L
Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
[TBL] [Abstract][Full Text] [Related]
15. Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine.
Blazevic V; Malm M; Arinobu D; Lappalainen S; Vesikari T
Hum Vaccin Immunother; 2016 Mar; 12(3):740-8. PubMed ID: 26467630
[TBL] [Abstract][Full Text] [Related]
16. Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs.
Yuan L; Geyer A; Hodgins DC; Fan Z; Qian Y; Chang KO; Crawford SE; ParreƱo V; Ward LA; Estes MK; Conner ME; Saif LJ
J Virol; 2000 Oct; 74(19):8843-53. PubMed ID: 10982326
[TBL] [Abstract][Full Text] [Related]
17. Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection.
Yang K; Wang S; Chang KO; Lu S; Saif LJ; Greenberg HB; Brinker JP; Herrmann JE
Vaccine; 2001 Apr; 19(23-24):3285-91. PubMed ID: 11312027
[TBL] [Abstract][Full Text] [Related]
18. Rotavirus vaccine administered parenterally induces protective immunity.
Conner ME; Crawford SE; Barone C; Estes MK
J Virol; 1993 Nov; 67(11):6633-41. PubMed ID: 8411366
[TBL] [Abstract][Full Text] [Related]
19. Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles.
Lappalainen S; Tamminen K; Vesikari T; Blazevic V
Hum Vaccin Immunother; 2013 Sep; 9(9):1991-2001. PubMed ID: 23777748
[TBL] [Abstract][Full Text] [Related]
20. Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge.
O'Neal CM; Clements JD; Estes MK; Conner ME
J Virol; 1998 Apr; 72(4):3390-3. PubMed ID: 9525668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]